We’re going to talk with Peter Pitts, President of Center for Medicine in the Public Interest, about the IRA, which is impacting every company in biotech. The Inflation Reduction Act, or IRA, authorizes the price negotiation for a group of medicines selected by the government and, interestingly, allows no public pronouncements after the fact, by the companies. Disclaimers The information contained in this website and podcast are purely informational and not considered investment...

Today we’re excited to have Subh Roy who will share his insights about how to get funding for your biotech. Disclaimer The information contained in this website and podcast are purely informational and not considered investment recommendations.  Tim Dougherty’s participation in Biotech Insights is separate and apart from his role as an investment advisor representative. Nothing contained herein may be construed as a recommendation or endorsement of any of the companies discussed. Tim...

Dr. Dennis Liotta is very humble but don’t let that fool you – underneath the poised demeanor he’s a impassioned drug discovery giant who has made a significant contribution to improving the disease state of the world’s poor. The information contained in this website and podcast are purely informational and not considered investment recommendations.  Tim Dougherty’s participation in Biotech Insights is separate and apart from his role as an investment advisor representative. Nothing...

Today we have four very special guests, some friends of mine, who are going to share with us the story behind all the momentum driving life sciences in Atlanta. · Eddie Lai represents the MetroAtlanta Chamber of Commerce · Courtney Law represents a group called Biolocity, which bridges Emory and Georgia Tech · Ryan Lawler is from Biosparks Labs, funded by Georgia Technology Ventures, supporting the life science community in Atlanta · Suna Lumeh is from a venture capital firm called...

Our guest today is Gaurav Byagathvalli, a Geoge Tech alum and the CEO of Piezo Therapeurtics, a company developing an innovative nucleic acid delivery platform for DNA and mRNA vaccines. Instead of using complicated equipment they use simplified circuits, analogous to what is in a lighter, to product the same impulse. They then use microneedles, which function as electrodes, to conduct those pulses into your skin resulting in highly targeted, localized delivery. Disclaimer The information...

Our guest today is Nolan Townsend, the CEO of LEXEO Therapeutics, which focused on expanding the application of crisper gene therapies past rare diseases where they’ve generally been applied to more prevalent kinds of diseases. What got me excited for the talk was the enthusiasm that Nolan expressed for the application of genetic therapies to more common diseases, which is where all the costs live. This could have a very broad impact on society’s healthcare systems. Disclaimer The...

Today I am really excited to have Charles Gellman, CEO of HiDO Health. HiDO is a company that is focused on using artificial intelligence to help patients manage their medications for chronic disease. Each year, almost 250,000 in America die as a result of medical errors associated with lack of adherence to a prescription schedule, making it the third largest cause of death in the US. Disclaimer The information contained in this website and podcast are purely informational and not...

Our guest today is Dr. Amy Baxter, the CEO of Pain Care Labs, a company dedicated to using mechanical platforms such as vibrating devices to alleviate fear and pain associated with needles as well as reducing muscular skeletal pain in adults.   Disclaimer The information contained in this website and podcast are purely informational and not considered investment recommendations.  Tim Dougherty’s participation in Biotech Insights is separate and apart from his role as an investment advisor...

This episode we’re doing something different. We’re visiting some of the most compelling stories and CEOs of our earlier editions, to update their journeys. I wanted to do this for two reasons. ·       The people in this industry are some of the grittiest, most determined, and most philanthropic, in terms of their commitment to their science and patients, people that I have ever known. ·       By following these individual journeys I hope somehow to demonstrate the incredibly fast pace of...

Recently on the Biotech and Life Science CEO’s podcast, we’ve been talking about the speed at which change is occurring in the life sciences. And nowhere is that clearer than in the field of mRNA. By now everyone must know that the COVID vaccines were created literally days after the genome of the virus had been sequenced. But I don’t think we’ve still processed what that really means. Our guest today is Dr. Pooja Tiwari, the founder of Arnav Biotech, dedicated to the design and manufacture...

In this podcast, we are joined by historian Dr. Nicolas Hoffmann who recounts a slew of quirky Civil War medicine stories that will have you rolling in laughter. Let’s go! Over the last few months of this podcast, we’ve had the opportunity to learn about tiny pill-sized endoscopes that can be swallowed and controlled on their path through the digestive tract by the healthcare provider. We’ve heard about the prospects for a universal flu vaccine whose chemistry would be consistent from one...

Today we are going to discuss advancements in improving the efficiency of those clinical trials. Our guest is Ian Strug who is the co-founder and Chief Revenue Officer at Virgo Surgical Video Solutions. Virgo provides cloud video capture, management, and artificial intelligence analysis for endoscopic medicine. Disclaimer The information contained in this website and podcast are purely informational and not considered investment recommendations.  Tim Dougherty’s participation in Biotech...

There are currently the following bottlenecks to the manufacturing of biologics, or medications such as gene therapies, vaccines, and etc. that are derived from organic sources such as plants or animals. The obstacles to large scale biologic dissemination are: 1. Delivering the biologic to the target 2. Manufacturing, producing it at scale 3. Selecting patients for clinical trials in a way that enhances the efficacy of the trial These challenges have, up until now, made biologics more...

In this episode we talk about gene algorithms with Raymond Peterson of DNA Analytics. The information contained in this website and podcast are purely  informational and not considered investment recommendations. Tim  Dougherty’s participation in Biotech Insights is separate and apart from  his role as an investment advisor representative. Nothing contained  herein may be construed as a recommendation or endorsement of any of the  companies discussed. Tim Dougherty has no financial...

In this podcast we welcome Harry Glorikian, an author, innovator, and podcast host in life sciences. In Harry’s book, The Future You, he alludes to artificial intelligence, or AI, as having the ability to unlock the language of life. In this podcast we discuss the impact that technology is having on the economics of healthcare, what the future hospital and doctor’s office of the future are likely to look like, and more! The information contained in this website and podcast are purely...

In this podcast we interview William Miller, MD, an evolutionary biologist, who is developing Cognition-Based Evolution as a novel peer-accepted alternative to conventional evolutionary theory. The information contained in this website and podcast are purely informational and not considered investment recommendations.  Tim Dougherty’s participation in Biotech Insights is separate and apart from his role as an investment advisor representative. Nothing contained herein may be construed as a...

In this podcast we interview Dr. Nikhil Shah, the CEO and Co-Founder of Nephrodite, Inc., an early-stage start up medical device company focused on developing an implantable continuous functioning dialysis device. Disclaimers The information contained in this website and  podcast are purely informational and not considered investment  recommendations. Tim Dougherty’s participation in Biotech Insights is  separate and apart from his role as an investment advisor  representative. Nothing...

In this podcast we’re pleased to welcome Jacob Glanville, the CEO of Centivax. He is working on a single, broad-spectrum vaccine, initially for the flu.

This is the story of Tan Rasab, the co-founder of SiGENEX, whose mission is to enable genetic testing at point of need at a price point reasonable to the common man. Read this inspirational interview to hear about the exciting innovations being made in genetic sequencing and what it may mean for hospitals, clinicians, patients, and society! Disclaimers The information contained in this website and podcast are purely informational and not considered investment recommendations. Tim...

In this episode we interview Abdulkader Rahmo, PhD, (nicknamed “AB”) co-founder, President and Chief Scientific Officer of SMSbiotech about the advances in stem cell research that he and his company have made. Lots of inspiration here! Disclaimers The information contained in this website and podcast are purely informational and not considered investment recommendations. Tim Dougherty’s participation in Biotech Insights is separate and apart from his role as an investment advisor...

In this episode of the Biotech and Life Sciences CEO podcast, we meet with Berkshire Biomedical CEO John Timberlake to discuss how they are making innovations in personalized medication delivery.   Through their COPA product, which stands for Computerized Oral Prescription Administration, they are coming up with new ways to ensure that liquid medications are delivered at the right time, in the right amount, and only to the authenticated, intended user.  For more episodes of inspirational...

Raised by hang-gliding hippies traveling through Mexico and South America, Torrey Smith later became a successful aerospace engineer. But the idea of sending in the nanobots to fix biological ailments inside human beings was a frustrating one for Torrey Smith. As he had only seen the idea conceptualized in  science fiction, he wondered why nobody has managed to achieve it in real life. And he just may become the first one to do it! In this interview we cover the career path of CEO Torrey...

Welcome to the podcast writeup for the Life Science and Biotech CEO stories podcast. In this episode we chat with Dr. Jayne Morgan who is the Director of the Covid Task Force at the Piedmont Healthcare Corporation in Atlanta, GA, a cardiologist, and a Covid vaccine expert. Dr. Morgan manages communications in a public health crisis for the entire state of Georgia – and a politically-charged one at that! We discuss Dr. Morgan’s efforts to educate the public about the Covid vaccine as an...